Vanda Pharmaceuticals to Announce Third Quarter 2012 Financial Results on November 7, 2012
Conference Call and Webcast to Follow
WASHINGTON, Oct. 17, 2012 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced it will release results for the third quarter of 2012 on Wednesday, November 7, 2012, before the market opens.
The Company will host a conference call at 10:00 AM ET on Wednesday, November 7, 2012, during which Vanda management will discuss the financial results. To participate in the conference call, please dial 1-800-299-7089 (domestic) or 1-617-801-9714 (international) and use passcode 66514556.
The conference call will be broadcast simultaneously and archived on the Company's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.
A replay of the call will be available on Wednesday, November 7, 2012, beginning at 12:00 PM ET and will be accessible until Wednesday, November 14, 2012, at 5:00 PM ET. The replay call-in number is 1-888-286-8010 for domestic callers and 1-617-801-6888 for international callers. The passcode number is 34968750.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. For more on Vanda Pharmaceuticals Inc., please visit http://www.vandapharma.com.
Company Contact:
Cristina Murphy
Senior Communications Manager
Vanda Pharmaceuticals Inc.
(202) 734-3400
cristina.murphy@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.
RELATED LINKS
http://www.vandapharma.com
More by this Source
Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder
Jun 17, 2013, 19:00 ET
Vanda Presents Data From Tasimelteon Phase III Studies In Non-24-Hour Disorder
Jun 05, 2013, 21:00 ET
Vanda Pharmaceuticals to Present at the Jefferies 2013 Global Healthcare Conference
May 31, 2013, 16:00 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.